Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 9/20 | 0.35 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | MIF | P14174 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15630169 | 0.95 | HSD17B10 (0.38) | HSD17B10FFAR1P2RY6EGLN1CA1 | |
| SCHEMBL15630171 | 0.95 | HSD17B10 (0.38) | HSD17B10FFAR1P2RY6EGLN1CA1 | |
| SCHEMBL12293196 | 0.93 | HSD17B10 (0.36) | HSD17B10FFAR1EGLN1 | |
| SCHEMBL2383871 | 0.92 | HSD17B10 (0.36) | HSD17B10FFAR1 | |
| SCHEMBL19013118 | 0.89 | HSD17B10 (0.36) | HSD17B10 | |
| SCHEMBL9356539 | 0.88 | HSD17B10 (0.34) | HSD17B10FFAR1 | |
| SCHEMBL890271 | 0.88 | HSD17B10 (0.34) | HSD17B10P2RY6CA1CA2 | |
| SCHEMBL15906283 | 0.86 | HSD17B10 (0.32) | HSD17B10EGLN1 | |
| SCHEMBL14721509 | 0.84 | FFAR1 (0.38) | HSD17B10FFAR1 | |
| SCHEMBL4598913 | 0.82 | P2RY6 (0.50) | HSD17B10P2RY6MIF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630796-B2 | System, device, and method for single-cell encapsulation and culture | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4741825-A1 | TEST KIT | Lifetrek Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025013724-A1 | TEST KIT | ライフトレック株式会社 | 2025-01-16 | — | — | WO | disclosed |
| US-20240201190-A1 | COMPOSITIONS AND METHODS OF DIAGNOSING PANCREATIC CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-20 | — | — | US | disclosed |
| CN-118191342-A | Quantitative detection kit and detection method for soluble fms-like tyrosine kinase-1 | 广州市丰华生物股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| US-11726091-B2 | Compositions and methods of diagnosing pancreatic cancer | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-08-15 | — | — | US | disclosed |
| US-20230174912-A1 | SYSTEM, DEVICE, AND METHOD FOR SINGLE-CELL ENCAPSULATION AND CULTURE | UNIVERSITY OF MARYLAND, COLLEGE PARK | 2023-06-08 | — | — | US | disclosed |
| WO-2021216789-A1 | SYSTEM, DEVICE, AND METHOD FOR SINGLE-CELL ENCAPSULATION AND CULTURE | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2021-10-28 | — | — | WO | disclosed |
| US-11112409-B2 | Systems and compositions for diagnosing pathogenic fungal infection and methods of using the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-09-07 | — | — | US | disclosed |
| US-10808024-B2 | Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins | TURUN YLIOPISTO (FI) | 2020-10-20 | — | — | US | disclosed |
| US-20040043502-A1 | Membrane-based assay devices that utilize time-resolved fluorescence | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-03-04 | — | — | US | disclosed |
| EP-0938678-B1 | METHOD AND KIT FOR THE DIAGNOSIS OF TROPONIN I | ABOATECH AB OY (FI) | 2003-09-03 | — | — | EP | disclosed |
| US-20030040024-A1 | Method and kit for the diagnosis of troponin I | HYTEST LTD. (FI) | 2003-02-27 | — | — | US | disclosed |
| US-6429026-B1 | One-step all-in-one dry reagent immunoassay | INNOTRAC DIAGNOSTICS OY (FI) | 2002-08-06 | — | — | US | disclosed |
| EP-1003778-A1 | ISOLATED OSTEOCALCIN FRAGMENTS | Hellman, Jukka (FI) | 2000-05-31 | — | — | EP | disclosed |
| EP-0938678-A1 | METHOD AND KIT FOR THE DIAGNOSIS OF TROPONIN I | OY Aboatech AB (FI) | 1999-09-01 | — | — | EP | disclosed |
| WO-1999009058-A1 | ISOLATED OSTEOCALCIN FRAGMENTS | HELLMAN JUKKA (FI) | 1999-02-25 | — | — | WO | disclosed |
| EP-0892927-A1 | ONE-STEP ALL-IN-ONE DRY REAGENT IMMUNOASSAY | Pettersson, Kim (FI) | 1999-01-27 | — | — | EP | disclosed |
| WO-1997049994-A1 | METHOD AND KIT FOR THE DIAGNOSIS OF TROPONIN I | OY ABOATECH AB (FI) | 1997-12-31 | — | — | WO | disclosed |
| WO-1997038311-A1 | ONE-STEP ALL-IN-ONE DRY REAGENT IMMUNOASSAY | PETTERSSON KIM (FI) | 1997-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10808024-B2 | Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins | VIP, HCCS, C3AR1 | HSD17B10 544/4885FFAR1 4462/4885P2RY6 4397/4885 |
| US-12630796-B2 | System, device, and method for single-cell encapsulation and culture | CD44, KIT, EPCAM | HSD17B10 4208/4885FFAR1 3763/4885P2RY6 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.